This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated quarter revenue up 52%, profit up 17% year on year
YATHARTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.2 pts more than Nifty Microcap 250 and 3.2 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated quarter ended September 30, 2026: revenue INR 4,314.20 million, up 52.4% year on year; net profit INR 484.59 million, up 17.5% year on year. Consolidated half-year revenue INR 8,240.74 million, net profit INR 938.82 million and positive operating cash flow INR 731.44 million. Tax orders total INR 680.35 million with interest; appeals are pending and no provision was made. Advent International's 24.9% stake awaits approvals.
Strong growth and cash flow support the stock, but slower profit growth, tax risks and possible dilution from Advent's 24.9% stake may cap gains.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹431.4 Cr | ₹279.4 Cr | +54.4% |
| Operating profit | ₹60.59 Cr | ₹45.33 Cr | +33.7% |
| Profit after tax | ₹48.46 Cr | ₹41.25 Cr | +17.5% |
| EBITDA margin | 23.6% | 23.1% | +0.6 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.